Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis

被引:32
作者
Gu, Jianchun [1 ]
Zheng, Leizhen [1 ]
Wang, Yajie [2 ]
Zhu, Meiling [1 ]
Wang, Qin [1 ]
Li, Xiaoping [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Oncol, Sch Med, Shanghai 200092, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Oncol, Shanghai 200433, Peoples R China
关键词
HER2; Human epidermal growth factor receptor; Gastric cancer; Prognosis; Meta-analysis; GROWTH-FACTOR RECEPTOR; ADENOCARCINOMA; OVEREXPRESSION/AMPLIFICATION; CHEMOTHERAPY; VALIDATION; PROTEIN; IMPACT;
D O I
10.1007/s13277-014-1693-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic significance of HER2 expression in patients with gastric cancer remains controversial, partially due to the significant heterogeneity of the approaches and criteria used for HER2 assessment among different studies. We therefore conducted a meta-analysis enrolling only studies defining HER2 status by trastuzumab for gastric cancer (ToGA) criteria. Published studies investigating the association between HER2 expression and survival were identified. Only publications that defined HER2 expression using ToGA criteria were enrolled. Meta-analyses were performed by Revman 5.2. Pooled hazard ratio (HR) and its 95 % confidence interval (CI) were calculated to evaluate the risk of disease. A total of 11 studies were enrolled in meta-analyses. Pooled data of nine studies using univariate analysis showed that HER2 expression is not associated with overall survival (OS; pooled HR, 0.97; 95 % CI, 0.84-1.12; P = 0.63), which are maintained in six studies of multivariate analysis (pooled HR, 1.01; 95 % CI, 0.75-1.35; P = 0.95). The Q statistic test for nine studies of univariate analysis and for six studies of multivariate analysis showed no and low heterogeneity (I (2) = 22 % and P = 0.25; I (2) = 41 % and P = 0.13, respectively). Furthermore, pooled data of four studies without heterogeneity (I (2) = 0 %, P = 0.74) showed that HER2 expression were not associated with relapse-free survival as well, with a pooled HR of 1.08 (95 % CI, 0.84-1.37; P = 0.55) in patients with HER2 expression. In conclusion, this meta-analysis indicated that HER2 expression based on ToGA criteria is not related to the survival in patients with gastric cancer.
引用
收藏
页码:5315 / 5321
页数:7
相关论文
共 36 条
[1]   Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population [J].
Aizawa, Masaki ;
Nagatsuma, Akiko K. ;
Kitada, Koji ;
Kuwata, Takeshi ;
Fujii, Satoshi ;
Kinoshita, Taira ;
Ochiai, Atsushi .
GASTRIC CANCER, 2014, 17 (01) :34-42
[2]   HER2 Testing in Gastric Cancer [J].
Albarello, Luca ;
Pecciarini, Lorenza ;
Doglioni, Claudio .
ADVANCES IN ANATOMIC PATHOLOGY, 2011, 18 (01) :53-59
[3]   Human epidermal growth factor receptor 2 (Her-2) and S-1 adjuvant chemotherapy in stage 2/3 gastric cancer patients who underwent D2 gastrectomy [J].
Aoyama, Toru ;
Yoshikawa, Takaki ;
Miyagi, Yohei ;
Kameda, Yoichi ;
Shirai, Junya ;
Hayashi, Tsutomu ;
Cho, Haruhiko ;
Oshima, Takashi ;
Yukawa, Norio ;
Rino, Yasushi ;
Masuda, Munetaka ;
Tsuburaya, Akira .
SURGERY TODAY, 2013, 43 (12) :1390-1397
[4]  
Bang YJ, 2010, LANCET, V376, P1302
[5]   The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel [J].
Bar-Sela, Gil ;
Hershkovitz, Dov ;
Haim, Nissim ;
Kaidar-Person, Orit ;
Shulman, Katerina ;
Ben-Izhak, Ofer .
ONCOLOGY LETTERS, 2013, 5 (02) :559-563
[6]   Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas [J].
Berezowska, Sabina ;
Novotny, Alexander ;
Bauer, Karina ;
Feuchtinger, Annette ;
Slotta-Huspenina, Julia ;
Becker, Karen ;
Langer, Rupert ;
Walch, Axel .
PLOS ONE, 2013, 8 (07)
[7]   Lymphatic vascular invasion is an independent correlated factor for lymph node metastasis and the prognosis of resectable T2 gastric cancer patients [J].
Bu, Zhaode ;
Zheng, Zhixue ;
Li, Ziyu ;
Zhang, Lianhai ;
Wu, Aiwen ;
Wu, Xiaojiang ;
Sun, Yu ;
Ji, Jiafu .
TUMOR BIOLOGY, 2013, 34 (02) :1005-1012
[8]   The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification [J].
Chae, Sumin ;
Lee, Anbok ;
Lee, Joo-Ho .
GASTRIC CANCER, 2011, 14 (02) :166-171
[9]   Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis [J].
Chen, Cheng ;
Yang, Jing-mo ;
Hu, Ting-ting ;
Xu, Ting-juan ;
Yan, Guang ;
Hu, Shi-lian ;
Wei, Wei ;
Xu, Wei-ping .
ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (05) :380-389
[10]   Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review [J].
Chua, Terence C. ;
Merrett, Neil D. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (12) :2845-2856